Vastned (LON:0ET5)
 30.10
 +0.10 (0.33%)
  At close: Nov 3, 2025
Vastned Revenue
Vastned had revenue of 16.85M EUR in the quarter ending June 30, 2025, with 242.77% growth. This brings the company's revenue in the last twelve months to 42.87M, up 121.64% year-over-year. In the year 2024, Vastned had annual revenue of 18.78M, down -1.03%.
Revenue (ttm) 
 42.87M EUR
Revenue Growth 
 +121.64%
P/S Ratio 
 11.57
Revenue / Employee 
 7.14M EUR
Employees 
 6
Market Cap 
425.00M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 18.78M | -196.00K | -1.03% | 
| Dec 31, 2023 | 18.98M | 1.47M | 8.39% | 
| Dec 31, 2022 | 17.51M | 717.00K | 4.27% | 
| Dec 31, 2021 | 16.79M | -114.00K | -0.67% | 
| Dec 31, 2020 | 16.91M | -2.36M | -12.25% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Shell | 200.18B | 
| BP p.l.c. | 134.89B | 
| Unilever | 51.24B | 
| HSBC Holdings | 43.13B | 
| AstraZeneca | 41.24B | 
| Rio Tinto Group | 39.22B | 
| GSK plc | 32.17B | 
| British American Tobacco p.l.c. | 25.60B |